Back to Search
HOUMAN AHDIEH, M.D.
M.D.
Ophthalmology Physician
NPI: 1659371060IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
MD055726L(PA)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
HAHNEMANN UNIVERSITY COLLEGE OF MEDICINE
Class of 1990
Research & Publications (14)
Efficacy of oxymorphone extended release in postsurgical pain: a randomized clinical trial in knee arthroplasty.
PMID 15199081·J Clin Pharmacol·2004
3-trial
Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain.
PMID 18950436·Pain Med·2008
3-trial
Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
PMID 17692717·Clin Ther·2007
4-observational
A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain.
PMID 17257473·Curr Med Res Opin·2007
4-observational
Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study.
PMID 17145204·J Pain·2007
2-rct
A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
PMID 16750450·Clin Ther·2006
3-trial
Efficacy and safety of oxymorphone immediate release for the treatment of mild to moderate pain after ambulatory orthopedic surgery: results of a randomized, double-blind, placebo-controlled trial.
PMID 16344024·Arch Phys Med Rehabil·2005
4-observational
Single- and multiple-dose pharmacokinetic and dose-proportionality study of oxymorphone immediate-release tablets.
PMID 15777102·Drugs R D·2005
3-trial
Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways.
PMID 15703368·J Clin Pharmacol·2005
2-rct
Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot study.
PMID 15538638·Support Care Cancer·2005
3-trial
The efficacy and safety of oral immediate-release oxymorphone for postsurgical pain.
PMID 15502051·Anesth Analg·2004
3-trial
Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study.
PMID 15200750·Curr Med Res Opin·2004
3-trial
Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: results of a randomized crossover study.
PMID 15098800·Pharmacotherapy·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1739 W FAIRMONT ST
ALLENTOWN, PA 18104 - Phone
- (610) 437-4988
Quick Facts
- NPI
- 1659371060
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 14
Are you this provider?
Claim Your Profile